Harvard Bioscience (HBIO) Revenue (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Revenue of $20.8 million for Q1 2026, down 4.68% year-over-year from $21.8 million in Q1 2025, and down 12.56% quarter-over-quarter from $23.7 million in Q4 2025.
Harvard Bioscience (HBIO) Revenue (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Revenue for 17 consecutive years, with $20.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue fell 4.68% year-over-year to $20.8 million; the TTM figure through Mar 2026 stood at $85.5 million (down 6.42% YoY), while the FY2025 annual figure was $86.6 million, down 8.06% from the prior year.
- Revenue eased to $20.8 million in Q1 2026 per HBIO's latest filing, from $23.7 million in the prior quarter.
- Across five years, Revenue topped out at $30.0 million in Q1 2023 and bottomed at $20.4 million in Q2 2025.
- Historically, Revenue has averaged $25.1 million across 5 years, with a median of $24.6 million in 2024.
- Annual changes were most pronounced in 2022 — Revenue increased 6.63% — and 2024, when it dropped 19.69%.
- Harvard Bioscience's Revenue stood at $28.4 million in 2022, then fell by 0.96% to $28.2 million in 2023, then slipped by 12.78% to $24.6 million in 2024, then slipped by 3.34% to $23.7 million in 2025, then declined by 12.56% to $20.8 million in 2026.
- Business Quant data shows HBIO's Revenue at $20.8 million in Q1 2026, $23.7 million in Q4 2025, and $20.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 2.89 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 4.98 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 2.82 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 1.46 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 7.69 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 872.30 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 2.21 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.08 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 2.96 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | 22.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.73 Mn |
| Mar 31, 2026 | 20.76 Mn |
| Dec 31, 2025 | 23.74 Mn |
| Sep 30, 2025 | 20.59 Mn |
| Jun 30, 2025 | 20.45 Mn |
| Mar 31, 2025 | 21.77 Mn |
| Dec 31, 2024 | 24.56 Mn |
| Sep 30, 2024 | 21.97 Mn |
| Jun 30, 2024 | 23.10 Mn |
| Mar 31, 2024 | 24.51 Mn |
| Dec 31, 2023 | 28.15 Mn |
| Sep 30, 2023 | 25.36 Mn |
| Jun 30, 2023 | 28.76 Mn |
| Mar 31, 2023 | 29.98 Mn |
| Dec 31, 2022 | 28.43 Mn |
| Sep 30, 2022 | 26.92 Mn |
| Jun 30, 2022 | 29.21 Mn |
| Mar 31, 2022 | 28.78 Mn |
| Dec 31, 2021 | 33.06 Mn |
| Sep 30, 2021 | 29.66 Mn |